Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signaling-Reference-Cited by-同舟云学术

Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signaling

Published:2021-06 Issue:4 Volume:21 Page:771-778
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Kawasaki Shuhei,Ohtsuka Hideo,Sato Yoshihiro^ORCID,Douchi Daisuke,Sato Masaki,Ariake Kyohei,Masuda Kunihiro,Fukase Koji,Mizuma Masamichi,Nakagawa Kei^ORCID,Hayashi Hiroki^ORCID,Morikawa Takanori^ORCID,Motoi Fuyuhiko^ORCID,Unno Michiaki^ORCID

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference42 articles.

1. Cancer statistics;Jemal;CA A Cancer J Clin,2010

2. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N Engl J Med,2013

3. Environment-mediated drug resistance: a major contributor to minimal residual disease;Meads;Nat Rev Canc,2009

4. Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids;Roodhart;Canc Cell,2011

5. Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer--a review;Dhayat;Int J Canc,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical significance and oncogenic function of LRRFIP1 in pancreatic cancer;Discover Oncology;2024-04-18

2. GCF2 mediates nicotine-induced cancer stemness and progression in hepatocellular carcinoma;Ecotoxicology and Environmental Safety;2024-02

3. GPX3 represses pancreatic cancer cell proliferation, migration and invasion, and improves their chemo‑sensitivity by regulating the JNK/c‑Jun signaling pathway;Experimental and Therapeutic Medicine;2024-01-29

4. Identification of hub genes associated with human cystic fibrosis: A Meta-analysis approach;Human Gene;2023-02

5. Exploration of the System-Level Mechanisms of the Herbal Drug FDY003 for Pancreatic Cancer Treatment: A Network Pharmacological Investigation;Evidence-Based Complementary and Alternative Medicine;2022-05-10